In this episode of Paul Talks Science, host Paul Adepoju sits down with Michael Moreland, founder of Field, to explore groundbreaking innovations in maternal, newborn, and child healthcare across Africa. They discuss how Field’s tech-driven solutions are helping save lives by optimizing health supply chains, supporting local pharmacies, and enhancing care at the grassroots level. With a recent $11 million commitment from the Gates Foundation, Field is scaling up access to life-saving interventions in regions where maternal mortality rates remain critically high. Tune in to learn how practical, scalable tech is transforming health systems, empowering communities, and redefining the future of healthcare access worldwide.

In this episode of Paul Talks Science, host Paul Adepoju, PhD, sits down with Paul Cheruiyot, head of programs at the International Federation of Red Cross and Red Crescent Societies (IFRC). Together, they delve into the vital role the Red Cross plays in responding to global health emergencies. From navigating the complexities of COVID-19 vaccine distribution across continents to addressing emerging threats like Monkeypox, the conversation highlights how the Red Cross mobilizes communities, partners with organizations like African CDC and the MasterCard Foundation, and supports public health infrastructure.

Cheruiyot shares insights on how the Red Cross's strategic approach to public health has evolved, not just in conflict zones but also in times of peace. Whether through emergency response, community health workforce development, or preparing for the next pandemic, this episode provides a behind-the-scenes look at one of the world’s most important humanitarian organizations.

Tune in to learn more about the Red Cross’s work at the intersection of health and humanitarian aid, and how it’s helping to shape the future of global health.

Perfect for listeners interested in public health, global health policy, and humanitarian response!

Welcome to the Paul Talks Science podcast. On this episode, I have a timely and important conversation about the race to develop a vaccine for the Marburg virus. Marburg is a rare but deadly viral haemorrhagic fever that has recently emerged in Rwanda, sparking global concern.

Read my interview with the health minister of Rwanda on how the country is controlling the disease. The interview was published by Scientific American, and you can read it here.

You can read an article that I wrote for The Lancet on the Marburg virus vaccine efforts here.

Joining me on this podcast is Mark Feinberg, the President and CEO of the International AIDS Vaccine Initiative (IAVI). IAVI has been working on a Marburg vaccine candidate for years, and their efforts have taken on new urgency with this latest outbreak.

In this interview, Mark will share insights on IAVI's vaccine development process, the current state of the pipeline, and the challenges of preparing for unpredictable outbreaks like Marburg. We'll also discuss the broader landscape of global health preparedness and the need for coordinated responses to emerging infectious diseases.

This is a fascinating look at the high-stakes work happening behind the scenes to protect us from deadly viruses. Let's dive into the conversation.